← Back to Search

Educational Video for Latent Tuberculosis

N/A

Waitlist Available

Research Sponsored by Kaiser Permanente

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Receipt of an LTBI treatment prescription order with specific medication ID codes for Isoniazid, Rifampin, Isoniazid + Rifampin, and Isoniazid + Rifapentine

Age ≥18 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year after treatment prescription

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether a 3-minute educational video can improve treatment completion rates for latent tuberculosis.

Who is the study for?

Adults who are members of Kaiser Permanente Southern California, diagnosed with latent tuberculosis (LTBI), and have been prescribed treatment. Participants must be at least 18 years old and not have an active TB diagnosis.

What is being tested?

The trial is testing if a short educational video sent to patients via text or email can increase the completion rates of LTBI treatment compared to standard care without the video. Patients will be randomly assigned to either receive the video or continue with standard care.

What are the potential side effects?

Since this intervention involves watching an educational video, there are no direct medical side effects associated with it. However, participants' perceptions and engagement with the video content will be evaluated.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been prescribed medication for latent TB infection.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year after treatment prescription

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year after treatment prescription

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year after treatment prescription for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Treatment completion

Secondary study objectives

Treatment completion by treatment regimen

Treatment initiation

Treatment initiation by treatment regimen

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: LTBI video interventionExperimental Treatment1 Intervention

Patients randomized to the intervention group will be sent an invitation with a link to watch a brief (\~3 minute video) about the importance of taking and completing LTBI treatment.

Group II: Standard careActive Control1 Intervention

Patients who are randomized to receive standard of care will not receive any messages or have any contact with the research team.

0 / 2Eligibility criteria met